Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. Takigami
P2.12-09 Efficacy and Safety of Carboplatin and Paclitaxel for Patients Preexisting Interstitial Lung Disease With Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Safety of Adjuvant Chemotherapy With Carboplatin and Weekly Paclitaxel for Pathological Stage IB-IIIB Non-Small Cell Lung Cancer
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
P2.12-18 Interstitial Lung Abnormalities Are a Risk Factor for Radiation Pneumonitis in Patients With Limited-Stage Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P2.17-21 Efficacy of Concurrent Carboplatin-Paclitaxel Chemoradiotherapy With 66 Gy for Elderly Patients With Stage III Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Vorinostat Increases Carboplatin and Paclitaxel Activity in Non-Small Cell Lung Cancer Cells
International Journal of Cancer
Cancer Research
Oncology
Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients With Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy
Journal of Cancer
Oncology
Dose-Finding and Sequencing Study of Paclitaxel and Carboplatin in Non-Small Cell Lung Cancer
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
P2.12-02 Phase II Study of Combination of Nab-Paclitaxel and Gemcitabine for Relapsed Small Cell Lung Cancer (SCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-32 a Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients With Interstitial Lung Disease
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Induction of Peripheral Effector CD8 T Cell Proliferation by Combination of Paclitaxel, Carboplatin and Bevacizumab in Non-Small Cell Lung Cancer Patients
Clinical Cancer Research
Cancer Research
Oncology
